REVEAL 2.0 Subscore Components Calculator

Clinical calculation support · Verify results before clinical use

Patient parameters

Enter the available clinical, functional, biomarker, and hemodynamic variables. Use either BNP or NT-proBNP.

13-variable model
Score +1 if <110 mmHg; otherwise 0.
Score +1 if >96 beats/min; otherwise 0.
≥440 m: −2; 320 to <440 m: −1; 165 to <320 m: 0; <165 m: +1.
Score +1 if <40% predicted; otherwise 0.
Score −1 if <5 Wood units; otherwise 0.
<50: −2; 50 to <200: 0; 200 to <800: +1; ≥800: +2.
<300: −2; 300 to <1100: 0; ≥1100: +2.
The published REVEAL 2.0 total is the sum of the applicable component points plus a baseline of 6 points. Complete the required clinical inputs and at least seven score variables; functional class, 6MWD, and one natriuretic peptide measure are core inputs for reliable use.

Scoring and interpretation

REVEAL 2.0 is a validated prognostic risk score developed for patients with pulmonary arterial hypertension (WHO Group 1). It combines clinical characteristics, functional status, biomarkers, pulmonary function, and hemodynamic information to estimate prognosis.

Risk categories

Total scoreCategory
0–6Low risk
7–8Intermediate risk
≥9High risk

Important scoring details

  • The total score includes a baseline correction of +6 points.
  • For the natriuretic peptide component, use BNP or NT-proBNP, not both.
  • For 6MWD, the score is −2 at ≥440 m, −1 at 320 to <440 m, 0 at 165 to <320 m, and +1 at <165 m.
  • PVR <5 Wood units contributes −1 point; PVR ≥5 contributes 0 points.
  • Risk categories refer to the REVEAL 2.0 prognostic model and should not be confused with the separate ESC/ERS three-strata follow-up assessment.

References

Benza RL, Gomberg-Maitland M, Elliott CG, et al.Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies. Chest. 2019;156(2):323–337. doi:10.1016/j.chest.2019.02.004
Benza RL, Kanwar MK, Raina A, et al.Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension. Chest. 2021;159(1):337–346. DOI record
REVEAL 2.0 scoring tableSupplementary scoring details published with the REVEAL Lite 2 paper. Full text and scoring table
Clinical disclaimer: This calculator is an educational clinical support tool and does not replace specialist assessment, validated clinical workflows, or current guidelines. Use in the intended population (Group 1 PAH) and verify entered values, measurement timing, and the applicability of each variable. Do not use the score in isolation to determine treatment or disposition.